Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide

Background: Although the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) has dramatically improved in the past decade, it is still compromised by transplant-related mortality (TRM), mainly caused by Graft-vs. -Host Disease (GvHD). Methods: We conducted a prospective observa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Greco, Raffaella, Lorentino, Francesca, Nitti, Rosamaria, Lupo Stanghellini, Maria Teresa, Giglio, Fabio, Clerici, Daniela, Xue, Elisabetta, Lazzari, Lorenzo, Piemontese, Simona, Mastaglio, Sara, Assanelli, Andrea, Marktel, Sarah, Corti, Consuelo, Bernardi, Massimo, Ciceri, Fabio, Peccatori, Jacopo
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2019
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6779849/
https://ncbi.nlm.nih.gov/pubmed/31632401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02319
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires